Floatz logo

ENGINEERED TOXIN BODY (ETB) COMPRISING A CD20 SCFV AND A MODIFIED SHIGA-LIKE TOXIN A

Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

Molecular Templates, Inc.protein_peptidePhase 1/2Dormant
D
30/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
15/ 100
Competitive Position
95/ 100

Competitive context

212 Active assets in the Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma cohort.

Asset / SponsorPhaseRating
ETOPOSIDE
Weill Medical College of Cornell University
Phase 2BBB
CHLORAMBUCIL
Ascentage Pharma Group Inc.
Phase 4BBB
Apg-2575
Henan Cancer Hospital
Phase 3BBB
Irinotecan
IGM Biosciences, Inc.
Phase 2BBB
PREDNISONE TABLETS
AstraZeneca
Phase 3BBB

View all 50 →

Same molecule, other indications

ENGINEERED TOXIN BODY (ETB) COMPRISING A CD20 SCFV AND A MODIFIED SHIGA-LIKE TOXIN A is also rated in:

B-cell non-Hodgkin lymphomaDormant
D
Indicative ·
30 / 100
View asset →
relapsed/refractory diffuse large B-cell lymphomaDormant
D
Indicative ·
29 / 100
View asset →
non-Hodgkin lymphomaDormant
D
Indicative ·
29 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →